Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
Medicines in the 1990s: a Technological Forecast
1 July 1969
By 1990, the total cost of the National Health Service will probably have reached about £10,000 million of which about £1,300 million will be for medicines…
Innovation Balance of Payments: the Experience of the Pharmaceutical Industry
1 July 1967
Symposium held at the Imperial College of Science and Technology by the Office of Health Economics This book is a published version of the second series…
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
ONE of the problems in Britain today is that too little of its academic research is associated with successful innovation in industry. The result is that…
Science, Industry in the State
7 January 1965
Based on a series of six lectures discussing some of the special considerations which arise when a science based industry has the government as a major…
Finance of Medical Research
7 January 1964
The explosive progress of medical science during the past twenty-five years has brought about a revolution in the health of the community and in the problems…